1. Analytical Considerations When Developing an LC-MS/MS Method for More than 30 Analytes. (15th October 2019) Authors: Enders, Jeffrey R; Smith, Jeremy P; Feng, Sheng; Strickland, Erin C; McIntire, Gregory L Journal: Journal of applied laboratory medicine Issue: Volume 2:Number 4(2018) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analytical Considerations When Developing an LC-MS/MS Method for More than 30 Analytes. (1st January 2018) Authors: Enders, Jeffrey R; Smith, Jeremy P; Feng, Sheng; Strickland, Erin C; McIntire, Gregory L Journal: Journal of applied laboratory medicine Issue: Volume 2:Number 4(2018) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development and Validation of a Novel All-Inclusive LC–MS-MS Designer Drug Method. Issue 3 (14th November 2018) Authors: Strickland, Erin C; Cummings, Oneka T; Mellinger, Allyson L; McIntire, Gregory L Journal: Journal of analytical toxicology Issue: Volume 43:Issue 3(2019) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Movantik™ and the Frequency of Positive Naloxone in Urine. Issue 3 (28th December 2017) Authors: Wotring, Justin; Countryman, Sky; Wallace, Frank N; Strickland, Erin C; Cummings, Oneka T; McIntire, Gregory L Journal: Journal of analytical toxicology Issue: Volume 42:Issue 3(2018) Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗